269 related articles for article (PubMed ID: 18500934)
1. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
[TBL] [Abstract][Full Text] [Related]
2. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei.
Fenollar F; Rolain JM; Alric L; Papo T; Chauveheid MP; van de Beek D; Raoult D
Int J Antimicrob Agents; 2009 Sep; 34(3):255-9. PubMed ID: 19346107
[TBL] [Abstract][Full Text] [Related]
3. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
Lagier JC; Fenollar F; Lepidi H; Raoult D
J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
5. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro.
Fenollar F; Perreal C; Raoult D
Int J Antimicrob Agents; 2014 Apr; 43(4):388-90. PubMed ID: 24613421
[No Abstract] [Full Text] [Related]
6. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.
Feurle GE; Moos V; Bläker H; Loddenkemper C; Moter A; Stroux A; Marth T; Schneider T
J Infect; 2013 Mar; 66(3):263-70. PubMed ID: 23291038
[TBL] [Abstract][Full Text] [Related]
7. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium.
Boulos A; Rolain JM; Mallet MN; Raoult D
J Antimicrob Chemother; 2005 Feb; 55(2):178-81. PubMed ID: 15650004
[TBL] [Abstract][Full Text] [Related]
8. Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
Lagier JC; Fenollar F; Lepidi H; Giorgi R; Million M; Raoult D
J Antimicrob Chemother; 2014 Jan; 69(1):219-27. PubMed ID: 23946319
[TBL] [Abstract][Full Text] [Related]
9. Tropheryma whipplei endocarditis relapses after treatment with trimethoprim/sulfamethoxazole.
Fenollar F; Lagier JC; Rolain JM; Célard M; Bouchot O; Eicher JC; Lepidi H; Raoult D
Int J Antimicrob Agents; 2013 Jun; 41(6):592-4. PubMed ID: 23507410
[No Abstract] [Full Text] [Related]
10. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.
Feurle GE; Junga NS; Marth T
Gastroenterology; 2010 Feb; 138(2):478-86; quiz 11-2. PubMed ID: 19879276
[TBL] [Abstract][Full Text] [Related]
11. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada.
Blahna MT; Zalewski CA; Reuer J; Kahlmeter G; Foxman B; Marrs CF
J Antimicrob Chemother; 2006 Apr; 57(4):666-72. PubMed ID: 16464890
[TBL] [Abstract][Full Text] [Related]
12. Ocular Whipple's disease: therapeutic strategy and long-term follow-up.
Touitou V; Fenollar F; Cassoux N; Merle-Beral H; LeHoang P; Amoura Z; Drancourt M; Bodaghi B
Ophthalmology; 2012 Jul; 119(7):1465-9. PubMed ID: 22420960
[TBL] [Abstract][Full Text] [Related]
13. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
Lagier JC; Fenollar F; Lepidi H; Raoult D
J Antimicrob Chemother; 2011 May; 66(5):1188-9. PubMed ID: 21393129
[No Abstract] [Full Text] [Related]
14. Therapy for Whipple's disease.
Knaapen HK; Barrera P
J Antimicrob Chemother; 2007 Sep; 60(3):457-8. PubMed ID: 17623695
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
16. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological study of sulfonamide and trimethoprim resistance genes in Enterobacteriaceae.
Panbangred W; Jayanetra P; Pilantanapak A
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):175-84. PubMed ID: 2237584
[TBL] [Abstract][Full Text] [Related]
18. Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazole.
Lévy M; Poyart C; Lamarque D; Delchier JC
Am J Gastroenterol; 2000 Sep; 95(9):2390-1. PubMed ID: 11007254
[No Abstract] [Full Text] [Related]
19. Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease.
Bonhomme CJ; Renesto P; Desnues B; Ghigo E; Lepidi H; Fourquet P; Fenollar F; Henrissat B; Mege JL; Raoult D
J Infect Dis; 2009 Apr; 199(7):1043-52. PubMed ID: 19222368
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of pentamidine against Tropheryma whipplei.
Rolain JM; Fenollar F; Raoult D
Int J Antimicrob Agents; 2011 Dec; 38(6):545-7. PubMed ID: 22005072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
